AzTrials
AzTrials

AmblyopiaNCT04213066

Stochastic Resonance Applied to Amblyopia Training and the Plasticity of Brain

A study testing Portable tablet in people with Amblyopia and Amblyopia, Anisometropic, run by National Cheng-Kung University Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The prevalence of Taiwan's population with amblyopia is 2-5%. Amblyopia affects the daily life and learning ability. The human visual system can be developed normally with exposure of clear images on the retina, which often drive the development and projection of optic nerves progressively. Read more about this study

Who is it for?
Ages 4 to 8 yearsHealthy volunteers can take part
Conditions the study is for
Amblyopia, Amblyopia, Anisometropic
What is being tested?
Portable tablet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
No sites listed yet
Study dates
15 Jul 2013to 31 Jan 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 8 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Participants were 4-8 years old.
  • Participant had binocular or monocular best-corrected visual acuity (BCVA) of ≤0.8, or they exhibited binocular BCVA difference of ≥0.2.
  • Participant had the wearing of optimal spectacle correction.

Who cannot join

  • Children with deprivation amblyopia were excluded.
  • Children with ptosis were excluded.

About this study

The prevalence of Taiwan's population with amblyopia is 2-5%. Amblyopia affects the daily life and learning ability. The human visual system can be developed normally with exposure of clear images on the retina, which often drive the development and projection of optic nerves progressively. In general, the visual acuity progresses gradually with age. A normal vision is relatively mature until 8 years old. Several types of amblyopia (strabismic amblyopia, refractive amblyopia, and deprivation amblyopia) are identified. The refractive amblyopia and deprivation amblyopia must be corrected by wearing glasses or surgeries. Otherwise, amblyopia is often corrected by occlusion of the dominant eye or amblyopia training. The Cambridge Stimulator (CAM) with rotating grating is commonly used in clinic in Taiwan. The principle of the CAM allows subjects to draw pictures on the plate in coincidence with occlusion of the dominant eye. The parents have to go with their children to a hospital weekly. The CAM training is a stereotyped visuomotor behavior, which usually causes fatigue and uninteresting results for children.

Recently, some computer games have been incorporated with CAM training. However, their clinical impact on amblyopia is largely unknown. Moreover, most of studies don't have long-term tracking, and they only use limited assessments. In this project, a home-based training would be built for children with amblyopia. A CAM training with a hierarchical structure with story-based organization would be implemented in the tablet. It will save time for children and parents for traffic between the home and hospital. The CAM training with organized structure would increase acceptability and create subjects' motivation for long-term training. In addition, a stochastic resonance theory would be incorporated with the CAM training to potentiate the learning curve of a visuomotor skill in young children. Five systematic assessments, including visual acuity, grating acuity, contrast sensitivity, and 2 measurements of visual evoked potentials (VEPs), would be used. The investigators hypothesized that the rotating grating stimulation and stochastic resonance stimulation groups showed significant enhancement of the visual functions compared with the control group and performance of the VEPs toward better eye through the home-based training apparatus.

Being tested
Portable tablet
Keywords
Amblyopia, Amblyopic training, Contrast sensitivity, Grating acuity, Stochastic resonance, Visual acuity, Visual evoked potential
Medical subject headings
Amblyopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Portable tabletDevice

    Each training session was limited to 15 minutes a day, 5 days a week. The entire training period was 6 months.

Study groups in NCT04213066
Study groupRoleWhat they receive
Control groupActive comparatorThis group received eye-hand practice for drawing pictures.
Receives: Device: Portable tablet
Grating groupExperimentalThis group received eye-hand practice for drawing pictures with rotating grating stimuli of various spatial frequencies.
Receives: Device: Portable tablet
Random dot groupExperimentalThis group received eye-hand practice for drawing pictures with rotating grating stimuli of various spatial frequencies constructed by random dots of stochastic resonance.
Receives: Device: Portable tablet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual acuity (VA)

    Landolt C chart was used.

    Measured: Change from Baseline VA at 1, 2, 3 and 6 months

  2. Grating acuity (GA)

    Horizontal or vertical square-wave grating stimuli were used.

    Measured: Change from Baseline GA at 1, 2, 3 and 6 months

  3. Contrast sensitivity (CS)

    Circular-shape horizontal square-wave grating stimuli were used.

    Measured: Change from Baseline CS at 1, 2, 3 and 6 months

  4. Visual evoked potential (VEP)

    Transient VEP and Steady state VEP of the Cortical EEG were recorded.

    Measured: Change from Baseline VEP at 1, 2, 3 and 6 months

Secondary outcomes (1)
  1. Total practice duration

    Practice duration was recorded in the tablet.

    Measured: Throughout 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2019
  2. Study start15 Jul 2013
  3. Primary completion31 Jan 2016
  4. Study completion31 Jan 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04213066
Sponsor's protocol ID
A-BR-102-050-t
Status last verified
Dec 2019
First submitted
22 Dec 2019
Last updated
30 Dec 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Yeh WH, Lai LJ, Chang DW, Lin WS, Lin GM, Shaw FZ. Portable rotating grating stimulation for anisometropic amblyopia with 6 months training. Sci Rep. 2021 Jun 1;11(1):11430. doi: 10.1038/s41598-021-90936-7.

    PubMed 34075118

Questions about this trial

What is this clinical trial studying?

A study testing Portable tablet in people with Amblyopia and Amblyopia, Anisometropic, run by National Cheng-Kung University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual acuity (VA) (time frame: Change from Baseline VA at 1, 2, 3 and 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04213066, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in